基于大麻的医药产品：英国国家卫生与临床优化研究所指南总结 - Suppr | 超能文献

相似文献

1

Cannabis-based medicinal products: summary of NICE guidance.基于大麻的医药产品：英国国家卫生与临床优化研究所指南总结

BMJ. 2020 Apr 21;369:m1108. doi: 10.1136/bmj.m1108.

2

Availability and approval of cannabis-based medicines for chronic pain management and palliative/supportive care in Europe: A survey of the status in the chapters of the European Pain Federation.在欧洲，用于慢性疼痛管理和姑息/支持性治疗的基于大麻的药物的可及性和批准情况：对欧洲疼痛联合会各章节现状的调查。

Eur J Pain. 2018 Mar;22(3):440-454. doi: 10.1002/ejp.1147. Epub 2017 Nov 13.

3

[Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy].[大麻对多发性硬化症、神经性疼痛患者以及接受化疗的肿瘤患者安全性和治疗效果的系统评价]

Epidemiol Prev. 2017 Sep-Dec;41(5-6):279-293. doi: 10.19191/EP17.5-6.AD01.069.

4

Cannabinoids in treatment-resistant epilepsy: A review.大麻素类药物在难治性癫痫治疗中的应用综述

Epilepsy Behav. 2017 May;70(Pt B):341-348. doi: 10.1016/j.yebeh.2016.11.012. Epub 2017 Feb 8.

5

Medical marijuana for cancer.医用大麻治疗癌症。

CA Cancer J Clin. 2015 Mar;65(2):109-22. doi: 10.3322/caac.21260. Epub 2014 Dec 10.

6

The use of medical-grade cannabis in patients non-responders to Nabiximols.医用大麻在对纳布西莫尔无反应患者中的应用。

J Neurol Sci. 2016 Sep 15;368:349-51. doi: 10.1016/j.jns.2016.07.059. Epub 2016 Jul 26.

7

Therapeutic issues of marijuana and THC (tetrahydrocannabinol).大麻和四氢大麻酚（THC）的治疗问题。

Int J Addict. 1985 May;20(5):691-9. doi: 10.3109/10826088509044289.

8

Epilepsy and cannabidiol: a guide to treatment.癫痫与大麻二酚：治疗指南

Epileptic Disord. 2020 Feb 1;22(1):1-14. doi: 10.1684/epd.2020.1141.

9

The US Food and Drug Administration's Authorization of the First Cannabis-Derived Pharmaceutical: Are We Out of the Haze?美国食品药品监督管理局对首款大麻衍生药物的批准：我们是否走出了阴霾？

JAMA Neurol. 2019 Feb 1;76(2):135-136. doi: 10.1001/jamaneurol.2018.3550.

10

Cannabis for the Treatment of Epilepsy: an Update.大麻治疗癫痫：最新进展。

Curr Neurol Neurosci Rep. 2018 Sep 8;18(11):73. doi: 10.1007/s11910-018-0882-y.

引用本文的文献

1

Cannabis, cannabinoids and health: a review of evidence on risks and medical benefits.大麻、大麻素与健康：关于风险和医学益处的证据综述

Eur Arch Psychiatry Clin Neurosci. 2025 Mar;275(2):281-292. doi: 10.1007/s00406-024-01880-2. Epub 2024 Sep 19.

2

Views and practices on medical cannabis of unlicensed providers in Thailand: a qualitative study.泰国无证提供者对医用大麻的看法和做法：一项定性研究。

F1000Res. 2024 Aug 27;11:365. doi: 10.12688/f1000research.110367.3. eCollection 2022.

3

The evolving culture of medical cannabis in Canada for the management of chronic pain.